544312 HAMPS

Hamps Bio Share Price

 

 

Start SIP in HAMPS

Start SIP
Hamps Bio live price: ₹19.79. It opened at ₹20 vs previous close ₹20; intraday high/low: ₹20/₹20. The 50 & 200 DMA stand at ₹19.35/₹24.65.

Hamps Bio Performance

  • Today's Low
  • ₹20
  • Today's High
  • ₹20
  • 52 Week Low
  • ₹13
  • 52 Week High
  • ₹35
  • Open Price₹20
  • Previous Close₹20
  • Volume4,000
  • 50 DMA₹19.35
  • 100 DMA₹21.48
  • 200 DMA₹24.65

Investment Returns

  • Over 1 Month + 13.09%
  • Over 3 Month + 9.88%
  • Over 6 Month -2.75%
  • Over 1 Year -7.95%

Smart Investing Starts Here Start SIP with Hamps Bio for Steady Growth!

Invest Now

Hamps Bio Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 57.9
  • PEG Ratio
  • -
  • Market Cap Cr
  • 17
  • P/B Ratio
  • 2
  • Average True Range
  • 1.35
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.68
  • RSI
  • 55.27
  • MFI
  • 43.57

Hamps Bio Financials

Hamps Bio Technicals

EMA & SMA

Current Price
₹19.79
-0.01 (-0.05%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11
  • 20 Day
  • ₹17.99
  • 50 Day
  • ₹19.35
  • 100 Day
  • ₹21.48
  • 200 Day
  • ₹24.65

Resistance and Support

19.79 Pivot Speed
  • R3 19.79
  • R2 19.79
  • R1 19.79
  • S1 19.79
  • S2 19.79
  • S3 19.79

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Hamps Bio Ltd. specializes in Pharmaceutical Formulation and Freeze-Dried Ingredients with two core divisions. Operating across Gujarat, Maharashtra, Rajasthan, and Madhya Pradesh, it serves B2B and B2C markets with therapeutic medicines and innovative freeze-dried food products.

Hamps Bio Ltd has an operating revenue of Rs. 17.14 Cr. on a trailing 12-month basis. An annual revenue growth of 5% is not great, Pre-tax margin of 6% is okay, ROE of 3% is fair but needs improvement. The company has a reasonable debt to equity of 23%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 4 which is a POOR score indicating inconsistency in earnings, a RS Rating of 72 which is FAIR indicating the recent price performance, Buyer Demand at E which indicates heavy supply, Group Rank of 152 indicates it belongs to a poor industry group of Medical-Whlsle Drg/Suppl and a Master Score of E is the worst. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Hamps Bio Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-14 Half Yearly Results (Revised) issue of equity shares in the ratio of 1:1 of Rs. 10/-.
2025-07-29 Bonus issue
2025-05-28 Audited Results
Date Purpose Remarks
2025-09-09 Bonus Rs.0.00 issue of equity shares in the ratio of 1:1 of Rs. 10/-.

Hamps Bio F&O

Hamps Bio Shareholding Pattern

71.99%
0%
24.06%
3.95%

Hamps Bio FAQs

Hamps Bio share price is ₹19 As on 06 April, 2026 | 17:13

The Market Cap of Hamps Bio is ₹17.2 Cr As on 06 April, 2026 | 17:13

The P/E ratio of Hamps Bio is 57.9 As on 06 April, 2026 | 17:13

The PB ratio of Hamps Bio is 2 As on 06 April, 2026 | 17:13

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23